Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

v3.24.1.1.u2
STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
R&D [Member]    
Total expensed for equity compensation $ 34,648 $ 77,383
G&A [Member]    
Total expensed for equity compensation 77,456 164,719
Members Of The Board Of Directors [Member]    
Total expensed for equity compensation 112,104 $ 242,102
20 private unregistered [Member]    
Proceed from stock issuances $ 1,103,326  
Issuance of shares of common stock 407,299  
Common stock sold to related parties 56,666  
Proceed from Common stock sold to related parties $ 130,782